These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Olfactory nerve stimulation-induced calcium signaling in the mitral cell distal dendritic tuft. Yuan Q; Knöpfel T J Neurophysiol; 2006 Apr; 95(4):2417-26. PubMed ID: 16319202 [TBL] [Abstract][Full Text] [Related]
25. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies. Femiano F Minerva Stomatol; 2002 Sep; 51(9):405-9. PubMed ID: 12473978 [TBL] [Abstract][Full Text] [Related]
26. Olfactory function assessed with orthonasal and retronasal testing, olfactory bulb volume, and chemosensory event-related potentials. Rombaux P; Weitz H; Mouraux A; Nicolas G; Bertrand B; Duprez T; Hummel T Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1346-51. PubMed ID: 17178947 [TBL] [Abstract][Full Text] [Related]
27. Olfactory dysfunction in Parkinson's disease. Kranick SM; Duda JE Neurosignals; 2008; 16(1):35-40. PubMed ID: 18097158 [TBL] [Abstract][Full Text] [Related]
28. Olfactory function following nasal surgery. Pade J; Hummel T Laryngoscope; 2008 Jul; 118(7):1260-4. PubMed ID: 18438263 [TBL] [Abstract][Full Text] [Related]
30. Olfactory dysfunction after head injury. Haxel BR; Grant L; Mackay-Sim A J Head Trauma Rehabil; 2008; 23(6):407-13. PubMed ID: 19033834 [TBL] [Abstract][Full Text] [Related]
31. Post-traumatic olfactory dysfunction: a cohort study and update. Collet S; Grulois V; Bertrand B; Rombaux P B-ENT; 2009; 5 Suppl 13():97-107. PubMed ID: 20084810 [TBL] [Abstract][Full Text] [Related]
32. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Carbone M; Pentenero M; Carrozzo M; Ippolito A; Gandolfo S Eur J Pain; 2009 May; 13(5):492-6. PubMed ID: 18675569 [TBL] [Abstract][Full Text] [Related]
33. Olfactory loss as a result of toxic exposure. Upadhyay UD; Holbrook EH Otolaryngol Clin North Am; 2004 Dec; 37(6):1185-207. PubMed ID: 15563910 [TBL] [Abstract][Full Text] [Related]
34. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Ziegler D; Reljanovic M; Mehnert H; Gries FA Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592 [TBL] [Abstract][Full Text] [Related]
35. Olfactory dysfunction as a diagnostic marker for Parkinson's disease. Haehner A; Hummel T; Reichmann H Expert Rev Neurother; 2009 Dec; 9(12):1773-9. PubMed ID: 19951136 [TBL] [Abstract][Full Text] [Related]
36. Essential tremor: mild olfactory dysfunction in a cerebellar disorder. Applegate LM; Louis ED Parkinsonism Relat Disord; 2005 Sep; 11(6):399-402. PubMed ID: 16102998 [TBL] [Abstract][Full Text] [Related]
37. The effect of Ginkgo biloba on the expression of intermediate-early antigen (c-fos) in the experimentally induced anosmic mouse. Lee GS; Cho JH; Park CS; Jung SH; Lee DH; Jun BC; Song CE; Cho KJ Auris Nasus Larynx; 2009 Jun; 36(3):287-91. PubMed ID: 19010624 [TBL] [Abstract][Full Text] [Related]
38. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials. Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583 [TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory and surgical therapy of olfactory disorders related to sino-nasal disease. Wolfensberger M; Hummel T Chem Senses; 2002 Sep; 27(7):617-22. PubMed ID: 12200341 [TBL] [Abstract][Full Text] [Related]
40. [The sense of smell in daily life]. Steinbach S; Hundt W; Zahnert T Laryngorhinootologie; 2008 Sep; 87(9):657-68; quiz 669-72. PubMed ID: 18726864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]